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Received October 4, 2010; accepted February 19, 2011AbstractBackground: Osteoarthritis (OA) is the most widespread chronic joint disease worldwide. Symptomatic knee OA is observed in approximately
12% of individuals more than 60 years of age. Conservative treatments models may not be effective always, and that some of them have serious
adverse effects that prompted the researchers to research different treatment methods. In this study, we investigated short- and mid-term
effectiveness of intra-articular pulsed radiofrequency (PRF) applied in patients with chronic knee pain due to OA.
Methods: This study was carried out in the pain management center of a university hospital between January 2009 and June 2009. The patient
record files of 31 patients who received intra-articular PRF were retrospectively reviewed. The antero-lateral area of the knee, where the
intervention would be applied, was anesthetized with 1% lidocaine. An introducer needle was placed intra-articularly. PRF was started as 42C at
2 Hz for 15 minutes. The pain of the patients was evaluated by 10 cm Visual Analog Scale (VAS). Furthermore, the ages, the gender, the
symptom duration of the patients, the side of the knee on which the intervention was applied, and the complications were collected for statistical
evaluation.
Results: Although the mean initial VAS scores of the patients were 6.1  0.9 cm, it was found, respectively, to be 3.9  1.9 cm and 4.1  1.9 cm
at the first- and sixth-month follow-ups. In general, a decrease of 32.8% in mean in the VAS scores was achieved in the last follow-up; whereas
the rate of patients reporting a minimum decrease of 2 points in the VAS scores was 64.5% and the rate of patients reporting a decrease of 50%
in their pain was calculated as 35.5%.
Conclusion: PRF applied to the knee joint appears to be an effective and safe method.
Copyright  2011 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Osteoarthritis (OA) is the most widespread chronic joint
disease worldwide. Its primary symptoms are pain, stiffness,
loss of function in the joints, and muscle atrophy.1e3 One of* Corresponding author. Dr. Haktan Karaman, Department of Anesthesiology,
Pain Management Center, Dicle University, Diyarbakir 21280, Turkey.
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1726-4901/$ - see front matter Copyright  2011 Elsevier Taiwan LLC and the C
doi:10.1016/j.jcma.2011.06.004the most incurred joints in OA is the knee joint, which carries
the heavy burden of the body.4 Knee OA is closely related
with increasing age and obesity. Symptomatic knee OA is
observed in approximately 12% of individuals aged more than
60 years.5 The conservative treatment of OA usually includes
physical therapy, analgesics including nonsteroidal anti-
inflammatory drugs (NSAIDs) and intra-articular steroid and
hyaluronan injections.6 Although conservative management
is effective in most OA patients, these treatments are not
effective in a small percentage of patients, and some of themhinese Medical Association. All rights reserved.
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research different treatment methods.
Minor and major surgical methods are also applied for
treatment of knee OA. The place of arthroscopy, which is
one of these methods, is controversial. It was reported that
arthroscopy would not be useful in cases where findings of
a meniscal rupture or a recent trauma do not exist.7 Another
method that can be applied for surgical treatment of OA is
total knee replacement. Despite the successful results ach-
ieved by total knee replacement, which is an option consid-
ered for end-stage knee diseases, a significant percent of the
patients continue suffering from pain despite total knee
replacement.8
As a general concept, pain treatment by radiofrequency
(RF) energy has had wide coverage in the pain management
practice for the past 30 years.9 In conventional radiofrequency
thermocoagulation (CRFT) applications, an electrode emitting
RF currents is placed on the target nerve and the destruction
of the nerve tissue is ensured by the heat produced.10 CRFT
has many fields of application such as “denervation of the
medial branch innerving the zygapophycial joint”, “dorsal
root ganglionotomy”, “intradiscal applications”, “percutaneous
cordotomy for treatment of malign pain”, and “trigeminal
radiofrequency ganglionotomy for treatment of trigeminal
neuralgia”.10
Pulsed RF (PRF) application is a relatively new method that
has been developed as an alternative to CRFT. PRF has much
less (if any) neurodestructive characteristic. In PRF, the RF
energy is applied at high voltage (typically 45 V) and with 20
millisecond bursts followed by 480 millisecond silent pha-
ses.11 Thus, because of the long silent phase, the tissue
temperature will be spread and will not exceed 42C. So, no
tissue damage will develop because the tissue temperature will
remain below 45e50C, which is considered as the irrevers-
ible tissue damage threshold.12 PRF, which can be applied in
a similar manner to CRFT applications (such as facet medial
nerve or trigeminal nerve applications), is distinguished
mainly by peripheral applications where CRFT is never
applied. PRF has been reported to be used successfully in
treatment of disorders such as myofascial trigger points,11
phantom limb pain,13 occipital neuralgia,14 meralgia par-
esthetica,15 and premature ejaculation.16 One of the fields
where PRF was claimed to be effective is that of intra-articular
applications.17,18
Based on a study published by Sluijter et al17 in 2008, we
have been applying intra-articular PRF for treatment of chronic
pain developing due to knee OA in our pain management
center. In this study, we intended to survey retrospectively the
cases where we applied intra-articular PRF, and to study the
effectiveness of this method.
2. Methods2.1. Study design and settingThis study was carried out with the approval of the Insti-
tutional Review Board and in a retrospective, noncontrolledmanner. All patients who participated in the study were
informed in written and verbal on the intervention to be
applied before application, and their written consents accept-
ing the intervention were obtained. The study and all inter-
ventions were carried out in the pain treatment center of
a university hospital. The files of the patients, on whose knee
joints PRF was applied between January 2009 and June 2009,
were reviewed independently by a physician who was not
involved in the study.2.2. ParticipantsThe following were used as the criteria for being included
in the study: (1) patients with a diagnosis of knee OA
according to The American College of Rheumatology
criteria19; (2) patients between Stage 1 and Stage 3 radiolog-
ically, according to the Kellgren-Lawrence classification20; (3)
patients who had continued to conservative treatment such
as physical therapy, analgesic drugs including NSAIDs or
opioids, for at least six months, but could not respond to the
treatment sufficiently [<2-point improvement in pain severity
by Visual Analog Scale(VAS)].
The following were used as the exclusion criteria for the
study: (1) patients at Stage 4 radiologically, according to the
Kellgren-Lawrence classification; (2) existence of general
contraindications against application of invasive intervention
(such as hemorrhagic diathesis, systemic infection, or local
infection at the area to be intervened); (3) excessive use of
opioid; (4)psychiatric disorders.2.3. ProceduresAll procedures were carried out under local anesthesia,
with blind technique, in the intervention room of the pain
treatment center. After the patients who would be intervened
were prepared according to the standard hunger protocol (6e8
hours of hunger), all of them had vascular access and were
given isotonic solution of 0.9%. Following the standard
monitorization (3-lead ECG, TA, pulsoxymetry), the patients
were seated in a chair. After the area to be intervened was
wiped with an iodine-based antiseptic solution, it was draped
according to the rules of sterility. The antero-lateral part of the
knee was palpated, and the entry point was anesthetized
with 1% lidocaine. An introducer needle with 22 G 100-mm
length and 10-mm active tip (Baylis Medical Inc., Montreal,
Canada) was placed intra-articularly through the predefined
area. After satisfactory placement, the stylet in the introducer
was removed and RF probe (Baylis Medical Inc., Montreal,
Canada) was placed through the introducer needle. Then, PRF
was applied with 42C temperature and a pulse width of 20
milliseconds, at 2 Hz for 15 minutes. Because the application
was not painful, sedoanalgesia was not applied to any patients
during the intervention. After the intervention was completed,
a plaster was applied to the entry point and the patients were
transferred to the recovery room. The patients who stayed in
this room for 30 minutes were monitored by the clinic nurse
for early complications and then discharged from hospital with
Table 1
Demographic characteristics of study patients
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normal life in the following days.Age (y) Mean  SD 62.8  9.3
Range 36e782.4. Outcome measurementsGender Women n (%) 22 (71)
Men n (%) 9 (29)
Duration of
symptom (mo)
Mean  SD 78.8  64.3
Range 6e240
Symptomatic
knee side
Right n (%) 2 (6.4)
Left n (%) 6 (19.4)
Bilateral n (%) 23 (74.2)
Treatment forms
applied before
Analgesic drugs (NSAIDs and/or opioids) 5 (16.1)
Analgesic drugs (NSAIDs and/or opioids) þ
physical therapy
15 (48.4)
Analgesic drugs (NSAIDs and/or opioids) þ
physical therapy þ intra-articular injection
11 (35.5)The pain of the patients was evaluated by a 10-cm VAS. In
this scale, “0” identifies the situation where no pain exists and
“10” identifies the most severe pain that can be imagined.
Because most of our patients did not experience pain unless
movement, pain severity was assessed on motion.
Furthermore, the ages, the gender, the duration of symptom,
and the side of the knee on which the intervention was applied
(right or left) were collected for statistical evaluation.
Additionally, if early or late complications developed, these
were also recorded for evaluation.(steroid or hyaluronan)
NSAID ¼ nonsteroidal anti-inflammatory drugs; SD ¼ standard deviation.2.5. Follow-up periodFrom all patients who received knee PRF between January
2009 and June 2009, only those who received PRF due to
OA and the follow-up notes of whom existed for the 1st
month and 6th month after the intervention were included in
the study.
The successful result criteria were determined as achieve-
ment of a decrease of at least 2 points in VAS scores when the
latest follow-ups were compared with the baseline.21,222.6. Statistical analysisAll data were analyzed using the Medcalc Version 10.3.0.0
(MedCalc Software, Mariakerke, Belgium) for Windows. We
used the paired samples t test with Bonferonni’s correction to
perform pairwise comparisons. We also used Spearman
correlation coefficients to assess the effects of various factors
on the outcomes. p < 0.05 was considered statistically
significant in all analyses. The values are given as
mean  standard deviation.
3. Results3.1. Demographic characteristicsFig. 1. Agraphic showing the change in time in VAS scores. ***p < 0.0001,
statistically significant difference when comparing the baseline scores.
CI ¼ confidence interval; VAS ¼ Visual Analog Scale.The knee PRF application was performed on a total of 49
patients between January 2009 and June 2009. From these
patients, those who received knee PRF for reasons other than
OA and those whose follow-up data are missing were
excluded from the study. Thus, the remaining 31 patients were
taken into statistical evaluation. The mean age of the patients
was 62.8  9.3 years, and 71% of them were women. The
mean symptom duration was 78.8  64.3 months. Twenty-
three patients had bilateral knee OA, all of them underwent
PRF application made bilaterally whereas 16.1% of the
patients took only analgesic drugs (NSAIDs and/or opioids)
and 35.5% of them had been treated with analgesic drugs
(NSAIDs and/or opioids) þ physical therapy þ intra-articular
injection (steroid or hyaluronan) before PRF applications.
(Table 1).3.2. Outcome dataAlthough the mean of the initial VAS scores of the patients
was 6.1  0.9 cm, these values were found, respectively, to be
3.9  1.9 cm and 4.1  1.9 cm at the 1st month and 6th month
follow-ups (Fig. 1). Thus, a decrease of 2.0  1.4 cm in mean
was achieved when the latest follow-up scores were taken as
reference in comparison with the baseline scores. Although
this decrease in VAS scores was found as a statistically
significant difference, no statistically significant differences
were found between the follow-up periods themselves (Table
2). In general, a decrease of 32.8% in mean of the VAS
scores was achieved at the last follow-up when compared with
the baseline.
The rate of the patients reporting at least 2 cm of decrease
in VAS scores in comparison with the baseline scores, which
we considered as success criteria, was found to be 64.5%. The
Table 2
Pairwise comparisons of all-time VAS scores
Factors Mean
difference
Standard
error
pa 95% CIa
VASbaseline VAS1 mo 2.161 0.286 <0.0001 1.435 to 2.887
VAS6 mo 2.000 0.254 <0.0001 1.356 to 2.644
VAS1 mo VAS6 mo 0.161 0.192 1.0000 0.648 to 0.325
a Bonferroni-corrected.
CI ¼ confidence interval; VAS ¼ Visual Analog Scale.
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comparison with that of the last follow-up was calculated as
35.5%.
The possible effects of various factors such as age, duration
of symptom and gender on the final outcomes were studied by
using Spearman’s coefficient of rank correlation (Table 3).
Although there is no correlation between gender (p ¼ 0.9643)
and age (p ¼ 0.1878) and the outcomes, an inverse correlation
was found between the pain duration of the patients
(p ¼ 0.0338) and amount of decrease in VAS scores.3.3. SafetyIn none of the patients, on whom the application was per-
formed, were found any major or minor complications in the
early or late period. In other words, no patients developed
hemorrhage, infection, increase in their existing complaints, or
thermal injury.
4. Discussion
Although it is still not understood completely how PRF
takes effect,17,18,23 laboratory reports suggest a genuine
neurobiological phenomenon altering the pain signaling,
which has been described as neuromodulatory.13 Sluijter
et al17 suggested the hypothesis that PRF may have dual effect
in intra-articular applications. In the first effect on the nervous
system, PRF causes suppression of the excitatory C-fiber
response and inhibition of the synaptic transmission.17,18
This effect explains the immediate pain relief effect of
PRF particularly observed in small joint applications. It isTable 3
Effect of various factors on the outcome
Variable Y Decrease in
VAS score
Decrease in
VAS score
Decrease in
VAS score
Variable X Sex Duration of pain Age
Sample size 31 31 31
Spearman’s coefficient
of rank correlation
0.00817 0.3823 0.240
Significance level 0.9643 0.0338* 0.1878
95% confidence Interval
for Spearman’s coefficient
of rank correlation
0.361 to
0.347
0.6487 to
0.03228
0.124 to
0.548
*Correlation is significant at the 0.05 level.
VAS ¼ Visual Analog Scale.suggested that PRF shows its second effect (which explains the
effectiveness observed particularly in large joint applications
such as knee and shoulder joints, and emerging gradually) over
the immune cells. According to this suggestion, the electric
field affects the immune cells and thus affects production of
proinflammatory cytokines such as interleukin-1b, tumor
necrosis factor-a, and interleukin-6. Therefore, it is suggested
that PRF affects the inter-cell communication by intermediary
of these cytokines and triggers, rather than a limited effect,
formation of possibly more generalized response.17
Unlike CRFT, PRF can be applied to peripheral nerves
because it does not cause neuronal damage, and to inside
joints because it does not cause tissue damage. However,
studies on intra-articular application of PRF are scarce and, as
far as we know, there are only two articles in the literature in
English. In a series of cases published by Sluijter et al17 in
2008, PRF was applied to various joints (cervical facet, knee,
shoulder, sacroiliac, atlanto-axial, and radiocarpal joints) of
six different patients who had arthrogenic pain. The authors
have reported that they have obtained excellent results from all
application in mid and long term. In another study,18 Halim
et al applied intra-articular PRF to atlanto-axial joints of 86
patients with cervicogenic headache. In this retrospective
study, the long-term effectiveness of PRF was studied, and the
rate of patients reporting 50% decrease in their pain scores
1 year after the application was reported as 44.2%.
The most important weakness of the present study is
that it was not a randomized controlled study, but only
a study designed, retrospectively. Hence, generalization of the
outcomes of our study to the society may not be very accurate.
However, though our study was a retrospective one, it gives an
encouraging view on the effectiveness of intra-articular PRF
application. The placebo-controlled, randomized, and double-
blind studies to be planned in future may provide more
objective information on effectiveness of intra-articular PRF
application. One shortcoming of our study is that it did not
have a long follow-up period. We do not know whether or not
this effectiveness observed in PRF application in the short- to
mid-term follow-up period will also continue in the long term.
To find the answer to this question, studies with long follow-up
periods should be carried out.
In conclusion, PRF, applied to knee joint of patients who
suffer from chronic knee pain due to OA and do not respond to
the conservative treatment methods sufficiently, seems to be an
effective and safe method. To discriminate it from placebo
response, prospective, randomized, and placebo-controlled
studies with long follow-up period are needed.
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